The characteristics of B-lymphoblastoid cell strains transformed by Epstein ± Barr virus (EBV) from normal individuals and Werner's syndrome (WRN) patients were compared. We continuously passaged cell strains from 28 WRN patients and 20 normal individuals for about 2 years corresponding to over 160 population doubling levels (PDLs). First, the WRN mutation signi®cantly suppressed the immortalization: all the 28 cell strains from WRN patients, as well as 15 out of 20 cell strains from normal individuals, died out before 160 PDLs mostly without developing a signi®cant telomerase activity. The remaining ®ve cell strains from normal individuals became moderately/strongly telomerase-positive and, three of them were apparently immortalized with an in®nitively proliferating activity. Second, the monitoring of the telomere length of both normal and WRN cell strains during the culture period suggests that the WRN gene mutation causes abnormal dynamics of the telomere: (1) a signi®cant proportion of WRN cell strains showed drastic shortening or lengthening of telomere lengths during cell passages compared with normal cell strains, and (2) WRN cell strains terminated their life-span at a wide range of telomere length (between 3.5 and 18.5 Kbp), whereas normal cell strains terminated within a narrow telomere length range (between 5.5 and 9 Kbp). The chromosomal aberration characteristic of WRN cells, including translocation was con®rmed in our experiment. We discussed the correlation between the chromosomal instability, abnormal telomere dynamics and inability of immortalization of the WRN B-lymphobloastoid cell strains.
Introduction
Werner's syndrome (WRN) is an autosomal recessive disorder causing symptoms of premature aging (Epstein et al., 1996; Goto et al., 1981; Martin, 1978) accompanied by rare cancers (Goto et al., 1996) . Human diploid ®broblasts have a ®nite proliferative life-span in vitro (Hay¯ick and Moorhead, 1961) , which is considered as a model of cellular senescence. Interestingly, ®broblasts from WRN patients are known to have a shortened life-span in vitro (Martin et al., 1970) . The WRN gene was mapped to chromosome 8 (Goto et al., 1992; Schellenberg et al., 1992) . Recently, Yu et al. (1996) identi®ed a gene mutated in WRN patients that encodes a protein signi®cantly similar to RecQ-type DNA helicases. They described 15 mutations, and we found four additional mutations in this gene Matsumoto et al., 1997; Oshima et al., 1996; Yu et al., 1996) . At least 83% of chromosomes of WRN patients had one of these mutations, while the remaining 17% of chromosomes were considered to have unrecognized mutations. These facts together indicate that the mutation of the RecQ-type helicase gene is responsible for WRN symptoms, as well as the in vitro senescence of ®broblasts. An intriguing question that leads from this ®nding is the molecular mechanisms underlying the cellular senescence. The problem of using WRN ®broblast cell strains to clarify this question is that they are usually not easy to obtain and they have a very limited life-span.
B-lymphoblastoid cell strains transformed by Epstein ± Barr virus (EBV) are the most readily available subjects from patients. Furthermore, they are very easy to manipulate. They are expected, therefore, to be useful to investigate WRN pathogenesis at molecular and cellular levels, provided that the WRN gene is expressed and has a biological function in the cells. Indeed, the following evidence supports this idea. First, chromosomal aberration, known as variegated translocation mosaicism (VTM), is a pathological phenotype of both ®broblasts and EBV-transformed B-lymphoblastoid cell strains (Salk et al., 1985a) . Second, impaired S-phase transit has been reported in EBVtransformed B-lymphoblastoid cell strains from WRN patients (Poot et al., 1992) . Third, hypermutable ligation of plasmid DNA ends has been reported in these cell strains of patients (Runger et al., 1994) . Fourth, the WRN gene was shown to be expressed in these cell strains as shown by Northern blot and RT ± PCR analyses Matsumoto et al., 1997) . We lack, however, some fundamental knowledge about EBV-transformed B-lymphoblastoid cell strains to use them to investigate the molecular mechanisms of WRN pathogenesis: for example, whether the Blymphoblastoid cell strains are mortal or immortal is unknown. Usually, these cell strains are considered to be immortalized (Miller, 1990) . On the other hand, fragmented results support that some of them are mortal: (1) two WRN patient-derived cell strains were reported to be mortal (Salk et al., 1985b) , and (2) two cell strains cloned from normal individuals were reported to be mortal provided that they lacked telomerase activity (Counter et al., 1994) . To systematically clarify the mortality and immortality of the cells, we carried out a long-term cell passage of established EBV-transformed lymphoblastoid cell strains from 28 WRN patients and 20 normal individuals. Their telomerase activity and the length of telomere were assessed simultaneously, since both of them are considered to be intimately correlated with cellular senescence and immortalization (Blackburn, 1991; Counter et al., 1994) . We found that WRN gene mutation caused abnormal dynamics of telomere length and suppressed the occurrence of immortalized cells with a strong telomerase activity.
Results

Life-span
More than 95% of the PBL samples from both normal individuals and WRN patients gave EBV-transformed B-lymphoblastoid cell strains, and the capability of transformation of the PBLs between them showed no dierence. The cell strains used in our experiment were con®rmed to possess Blymphoblastoid characteristics by staining the cells with anti-human immunoglobulins (Kataoka et al., manuscript in preparation). The EBV-transformed Blympho-blastoid cells were referred to simply as`Blymphoblastoid cells' in the text for convenience except where otherwise mentioned. We have continuously passaged the established B-lymphoblastoid cell strains from 28 WRN and 20 normal individuals for more than 2 years. At around 30 ± 50 PDLs, the cell strains from both groups began to stop proliferation one by one (Figure 1 ). All the 28 Figure 1 Maximal PDLs of B-lymphoblastoid cell strains from WRN patients and normal individuals. Mortal cell strains from normal individuals (*); immortalized cell strains from normal individuals (*); mortal cell strains from the near relatives of patients (^); an immortalized cell strain of the brother of a patient (^); mortal cell strains of WRN patients (~). The asterisk indicates that the cell line showed a strong telomerase activity at later stages of PDLs WS6801  WS5801  WS6501  WS0101  WS2101  WS11001  WS23702  WS23703  WS10402  WS24002  WS9101  WS9801  WS10201  WS10501  WS10901  WS11201  WS9601  WS10101  WS10801  WS11301  WS11601  WS0701  WS0702  WS0801  WS6201  WS11801  WS11901  WS12301   45F  42M  50F  30M  49F  38F  45M  51M  39F  47F  52F  42M  43F  53F  60F  49F  48F  38F  38F  48F  38F  52M  50F  42F  42F  39F  35M  42M ? 69  67  57  52  95  143  124  105  86  99  90  111  157  55  123  93  63  83  141  148  142  56  43  80  97  99  115  103   N0102  N0103  N0104  N4702  N6803  N7401   N0001  N0002  N0003  N0004  N0005  N0006  N0007  N0008  N0009  N0010  N0011  N0012  N0013  N0014   27F  60M  60F  52M  50M  50M   100F  97F  95F  97F  99M  29M  35M  51M  54M  0M  0M  25F  53F  30M The donors with`WS' are WRN patients with WRN mutation and those with`N' are normal individuals, among which donors from NO102 to N7401 are the parents or brothers and sisters of patients. For patients, mutations 1 to 10 were analysed. For normal inividuals, three major mutations (mutations 1, 4 and 6) were analysed and`7' means negative for these mutations . Mutations 1 ± 4 are described in ; mutation 6 is a C to T substitution at nucleotide 1366 ; mutation 7 is a deletion of A at nucleotide 3677 
Telomerase activity
Telomerase activity was monitored at about 15 ± 30 PDL intervals during cell passages (Table 2 ). Figure 2 shows ITAS-TRAP examples which are classi®ed by HPA-TRAP into strong (S), moderate (M), weak (W) and negative (N) telomerase activities. Typical 6-base ladder was RNase-sensitive and primer-dependent. Discontinuous weak ladder was sometimes RNase resistant suggesting PCR artifact, and was de®ned as telomerase negative. Mixing experiments of telomerasenegative and telomerase-positive cell extracts indicated that telomerase negative cell extract did not contain a signi®cant activity inhibiting telomerase activity. At early stages of PDLs, more than half of the cell strains from both normal individuals and WRN patients showed a weak or moderate telomerase activity while the remaining cells showed no detectable activity. A large proportion of the cell strains tended to lose telomerase activity with the progress of PDLs, regardless of whether they were derived from normal individuals or WRN patients, except for a few cell strains including immortalized ones. The presence of a weak or moderate telomerase activity in pre-crisis Blymphoblastoid cells was consistent with the observation by other investigators (Avilion et al., 1996; Norrback et al., 1996) . Four normal cell strains, N6803, N0003, N0005 and N0010 became strongly telomerase-positive between 11 and 69 PDLs, between 110 and 167 PDLs, between 38 and 54 PDLs, and between 44 and 58 PDLs, respectively, and the N0013 strain became moderately positive at 141 PDLs (Table  2) .
Telomere length
The length of telomere was assessed by Southern blot analysis of the TRFs. Mean TRF size calculated from the highest density of smear pattern of Southern blot was only a rough approximation but was valuable enough to compare drastic changes. Figures 3 and 4 show changes in the TRF length during cell passage for the cell strains with longer life-spans of 100 PDLs or more. The telomere length did not necessarily shorten uniformly, and some cell strains restored, in average, a long telomere length after shortening in both WRN and normal cell strains. However, a comparison of the pro®les of telomere length clearly shows that the changes in telomere length of WRN cell strains were far more drastic than in normal cell strains (Figure 3) . Especially, the three cell strains, WS10801, WS11301 and WS11601, showed typical irregular patterns with repeated gain and loss of telomere (2)). In the WS11301 cell line, the gain of TRF length between 30 and 64 PDLs was calculated as 378 bp/PDL while the loss between 120 and 146 PDLs was calculated as 340 bp/PDL. Most of other WRN cell strains also showed similar rapid shortening and lengthening of telomere lengths. Such abnormal dynamics of telomere length was not so obvious in mortal or immortalized cell strains from normal individuals. The analysis of the DNAs by gel electrophoresis and staining with ethidium bromide showed that this abnormal dynamics of telomere length was not due to an artifact such as a simple degradation of DNAs. Our observations are quite dierent from those by Schultz et al. (1996) in ®broblasts: (1) the loss of TRF length per PDL was 58 and 108 bp/PDL for normal and WRN ®broblast cell strains, respectively, and (2) the telomere length of ®broblasts decreased uniformly. Both of the observations were, however, similar in that the rate of TRF shortening was sharper in WRN cells than in normal cells. These results indicate that the rate of the loss of TRF length of WRN B-lymphoblastoid cell strains was much higher than the rate of WRN ®broblasts. The two immortalized cell strains, N6803 and N0005, showed relatively constant TRF lengths after they became strongly telomerase-positive between 54 and 69 PDLs (Table 2, Figure 3 ). Another immortalized cell line, N0003, uniformly shortened its telomere length to attain 8610 3 bp at 135 PDLs, when the telomerase activity obviously increased. Figure 4 shows the change in TRF length with the progress of PDLs in Southern blot analyses; the N4702 cell line showed a uniform decrease; the WS11301 and WS11601 cell strains showed a complete shortening and lengthening; the N0005 cell line at ®rst shortened its TRF length followed by keeping the length at around 60 PDLs after they became strongly telomerase-positive. Figure 5 shows the distribution of TRF length determined at the PDLs nearest to the end of their lifespan (terminal TRF length). The terminal TRF length of normal cell strains centered at a narrow range between 5.5 and 9 Kbp. On the other hand, the terminal TRF length of WRN cell strains distributed widely from 3.5 to 18.5 Kbp.
To investigate the localization of telomere at each chromosomal terminal, we also observed telomeres by staining cells with PRINS. Figure 6a and b show the PRINS pro®les of metaphase at 32 and 62 PDLs of the S11301 cell strain, and Figure 6c and d show the pro®le of metaphase at 58 and 82 PDLs of the WS11601 cell strain (Figure 3, WRN (2) ). Although PRINS was not quantitative enough for determination of each TRF size and both cells showed small and medium-sized signals, larger signals were found only in the cells at the elongating phase of the TRF as observed by Southern blot (Figure 6b and d) . The results of PRINS indicate that the size of telomere varied even in a single cell regardless of whether they were derived from normal or WRN cells and that the variation was larger in WRN cells at the TRF elongating phase. These EBV-transformed B-lymphoblastoid cells, especially those from WRN patients, likely correspond to the immortalized cells with heterogeneous telomeres derived from cloned cells with long homogeneous telomeres after cell passages, as described by Murnane et al. (1994) .
Analyses of chromosomes
The chromosomal aberration called VTM is a wellknown cytopathological event of WRN cells (Salk et 
Discussion
This study demonstrated that all 28 EBV-transformed lymphoblastoid cell strains from WRN patients were mortal. On the other hand, ®ve out of 20 normal cell strains are likely immortalized accompanied by a signi®cant telomerase activity, although the remaining 15 cell strains were mortal being unable to overcome a crisis. These results were consistent with the following previous observations. Salk et al. (1985a) preliminarily reported that among four B-lymphoblastoid cell strains, one normal cell line grew continuously over 180 PDLs, while one cell strain from a WRN brother (normal) and two WRN cell strains died out at 158, 54 and 88 PDLs, respectively. Counter et al. (1994) reported that two clonal telomerase-negative cell lines died out at 45 and 95 PDLs, while two telomerasepositive cell lines were immortalized. Bryan et al. (1995) reported that the in vitro transformed immortal ®broblasts showed, at high frequency, no telomerase activity along with aberrantly long telomeres. On the other hand, observations by ours as well as by Counter et al. (1994) strongly suggested an intimate correlation between the immortalization and development of strong telomerase activity. It could be either due to the dierences in the methods for transformation (EBV versus non-EBV) or in the types of cells (Blymphoblastoid cells versus ®broblasts) between these studies. In SV40-induced transformation of ®broblasts the cells are known to become immortalized after they experience the`crisis' (Girardi et al., 1965) . In our experiment, among the three immortalized B-lymphoblastoid cell strains, the N6803 cell strain showed an apparent crisis phase accompanied by a decreased activity of cell growth, while the remaining two cell strains, N0003 and N0005, did not show an apparent crisis. In addition, two telomerase-positive cell strains, N0010 and N0013 not yet reaching the limit PDLs of immortalization (160), also overcame a crisis. Taking into consideration that each culture bottle contained about 5 ± 10610 6 cells and that ®ve telomerasepositive immortalized cell strains arose out of 20 normal cell strains, the frequency of immortalization was calculated roughly as 2.5 to 5 in 10 8 crisis cells in the experimental system of this study. This frequency was not necessarily high compared with the frequency calculated for the SV40-induced immortalization of ®broblasts ranging from 1 in 10 5 to 1 in 10 9 crisis cells (Bryan and Reddel, 1997) . Therefore, although the peripheral blood cells from virtually all normal individuals were transformed by EBV to a cell strain with a long-term growth (about 90 PDLs on average), most of them were clearly mortal in that they were usually not able to exceed 160 PDLs. A rare cell, 2.5 to 5 in 10 8 , was considered to be immortalized and gain strong telomerase activity leading to continued proliferation beyond this limit. The immortalization in WRN cell strains are considered to be much rarer compared with normal cell strains.
Why were the immortalized cells so rare in WRN cell strains? First, the increased chromosomal aberration in WRN cells may result in accumulation of chromosomal damage more quickly in WRN cells than in normal cells. If so, a rare immortalized cell positive for telomerase, if it appears, cannot expand due to an extensive chromosomal damage. In other words, this suggests that a normal WRN gene is essential for in®nite proliferation of immortalized cells that avoid the excess accumulation of chromosomal damage. The accumulation of chromosomal damage may be correlated to the observation by Poot et al. (1992) that the S-phase transit of cell cycle is impaired in EBV-transformed lymphoblastoid cell strains from WRN patients. Second, it is possible that TRF lengths of WRN cell strains are more variable than those of normal cell strains, and that the TRF length of a speci®c telomere shortens below a critical length leading to cell death while the average TRF length remains relatively long. In other words, a signi®cant proportion of WRN cells died, even when they, as a cell population, had relatively long TRFs (12 ± 18 Kbp) ( Figure 5 ). This event of B-lymphoblastoid cell strains in our study was apparently consistent with the observation by Schulz et al. (1996) that WRN ®broblasts stopped proliferation at longer TRF than normal ®broblasts. The chromosomal instability of WRN cells with the resultant accumulation of chromosomal damage may also have a role in this phenomenon. Third, normal WRN helicase may be required to triggr telomerase activation, although we do not have any evidence either to support or negate this possibility.
The B-lymphoblastoid cell strains cultured for longterms from WRN patients showed higher instability of telomere length than the corresponding normal cell strains: the telomeres showed a drastic shortening and lengthening. An immortal human ®broblasts derived from SV40-transformed cells have no telomerase activity and showed a dynamic change in telomere size (Murnane et al., 1994) . Chemical or gamma-ray treated human ®broblasts also elongated TRF size during immortalization (Sugihara et al., 1996) . A similar phenomenon was reported in yeast and in immortalized T-cell and B-cell lines (Lundblad and Blackburn, 1993; Strahl and Blackburn, 1996) . Lundblad and Blackburn (1993) proposed that telomere lengths in yeast and these lymphoid cell lines are determined by both telomerase and telomeraseindependent mechanisms. A similar hypothesis was proposed by Reddel et al. (Bryan et al., 1995; Bryan and Reddel, 1997) . Since most of the long-term cell strains over 100 PDLs from both WRN patients and normal individuals had no or only weak telomerase activity, cells from WRN patients may extraordinarily activate telomerase-independent mechanisms which is activated only moderately in wild type cells.
Since all the cell strains of this study were derived from mass culture, selection of cells with longer TRFs would occur during cell passage. This may partly explain the dominance of cell populations with longer TRFs in some cell strains, especially at their younger PDLs. This explanation, however, cannot be used to interpret the sharp lengthening of TRFs occurring at mid/later PDL phases, since the cells were diluted by a half at every passage. The analysis of cell surface immunoglobulin at later PDLs also support this speculation, since the cell population at later PDLs were relatively homogeneous (clonal) as judged by the analyses of surface immunoglobulin by¯ow cytometer (Kataoka et al., manuscript in preparation).
From these results, we suggest the possibility that non-reciprocal recombination between telomere repeats as shown in yeasts (Lundblad and Blackburn, 1993) results in an increase in telomere repeats in Blymphoblastoid cell strains. If this were the case, enhancement of this process by the WRN gene mutation would be possible, since recombination events seem to be activated in WRN cells as speculated from the increased occurrence of chromosomal aberration in WRN cells, including translocation (Figure 7 ; ref. Salk et al., 1985a) . Guarente (1996) proposed the possibility that the WRN gene mutation indeed stimulates recombination between repetitive DNA sequences, since mutation in sgs1, a gene coding the RecQ-type helicase gene of yeast, is known to increase recombination within the hundreds of copies of ribosomal DNA that are tandemly repeated in the genome (Ganglo et al., 1994) . Whether or not the WRN gene really increase the recombination at telomeres remained to be clari®ed.
Materials and methods
Patient samples
Blood samples were collected from normal individuals and WRN patients. WRN was diagnosed from at least three of the following four major signs and symptoms (Goto et al., 1981) : (1) characteristic disposition and stature; (2) premature senescence; (3) scleroderma-like skin changes; and (4) endocrinological abnormalities. The presence or absence of WRN gene mutations 1 ± 10 in WRN patients and normal individuals was investigated as previously reported Yu et al., 1996; Matsumoto et al., 1997) . Table 1 shows the blood donors of WRN patients and normal individuals, including the parents or brothers and sisters of the patients. Chromosomes from normal random individuals have none of these mutations .
Establishment of B-lymphoblastoid cell strains, cellular passage and judgement of maximal PDLs
Peripheral blood leukocytes (PBLs) of patients were puri®ed by a Lymphocyte Separation Medium (West Chester, PA) and were transformed by EBV propagated in marmoset cell line B95-8 (Miller, 1990) in the presence of 200 ng of Ciclosporin (Sandoz, Switzerland). Established cell strains were cultured in 25 cm 2 bottles (Corning, NY) standing¯at, using RPMI1640 medium (Nissui Pharmaceutical Co. Ltd., Tokyo) supplemented with 10% fetal calf serum, (Gibco, NY), Bath No. 30F6131C), 50 units/ml of penicillin G and 50 mg/ml of streptomycin sulfate (Sigma, St Louis), and 0.25 mg/ml of Fungison (Gibco BRL, NY at 378C in 7.5% CO 2 atmosphere. Continuous cellular passages were carried out every 3 or 4 days (twice a week) by exchanging a half volume of cultivating cell suspension with a fresh medium. During the 3 ± 4 day culture period, the cells usually attained a maximal cell density of betwwen 1 to 2610 6 /ml for both normal and WRN cell strains. All the cell strains were judged to be free of mycoplasma using Mycoplasma Primer Set (Stratagene, La Jolla, CA).
The maximal population doubling levels (PDLs) were judged as follows. At a crisis phase, the culture medium obviously shifted to an alkaline pH and the maximal cell density decreased. When the maximal cell density decreased to below about 2 6 10 5 /ml, the cells were transferred to a 6-well culture plate, and the culture was continued by changing a half of the supernatant medium. Usually, the cultured cells were watched for three weeks to two months under this condition. If they did not show a recovery of proliferation activity, the PDLs, when the cells were transferred to the 6-well plate culture were judged to be at their maximum. Occasionally, the cells showed a partial recovery after a crisis, but in all cases they stopped proliferation, with the exception of the N6803, N0010 and N0013 cell lines that will be mentioned in the Results section. At a crisis, the cells showed signi®cantly lowered proliferating activity as judged by the decreased incorporation of bromodeoxyuridine assessed by ā ow cytometer, Epics Elite ESP (Coulter Corporation, Miami) (Dolbeare et al., 1983) .
At every interval of about 20 to 30 PDLs, parts of all the cell strains were stored in a deep freezer at 71158C in fetal calf serum containing 10% dimethyl sulfoxide (Aldrich Chem Co, Inc., Milwaukee). Cells of appropriate PDLs were thawed and used for culture when necessary.
Cytogenetic analyses
Chromosomes were prepared by a conventional method (Freshney, 1987) : cells were arrested in metaphase by colcemid, ®xed in methanol/acetic acid (3:1) and spread on acid/alcohol-cleaned slides. They were then stained by the trypsin/Giemsa banding method. For each sample, 20 metaphase cells were examined. If chromosomal aberration, such as telomeric association, ring formation, translocation, deletion and addition, was observed, the cell was judged as abnormal. The chromosome analyses were done completely blind in an independent institute (BML Co. Ltd., Saitama).
Telomerase assay
We used a PCR-based modi®ed telomeric repeat amplification protocol (TRAP) assay to detect telomerase activity (Kim et al., 1994) . To measure the telomerase activity and to evaluate the inhibitor of Taq DNA polymerase in the cell extract, we used an internal telomerase assay standard (ITAS) for the TRAP assay (Wright et al., 1995) . The cell pellet (1610 5 ) was suspended in 200 ml of cold TRAP lysis buer in an Eppendorf safe-lock 2.0 ml tube, incubated for 30 min on ice, and centrifuged at 15 000 g for 20 min at 48C. The supernatant (ca. 180 ml) was collected, and aliquots were placed into two 1.5 ml tubes, rapidly frozen in liquid nitrogen, and stored at 7808C. The extract equivalent of 10 3 cells (2 ml) was incubated with 48 ml of 20 mM Tris-HCl (pH 8.3), 1.5 mM MgCl 2 , 68 mM KCl, 0.05% Tween 20, 1 mM EGTA, 50 mM dNTP, 1 mg (0.5 mM) T4g32 protein, 5 mg BSA, 2 units Taq DNA polymerase (AmpliTaq; PerkinElmer/Cetus), a-[ 32 P]dCTP (148 KBq/assay, 110 TBq/mmol) (Amersham Co., Ltd.), 5 attg ITAS DNA and 0.1 mg of extra puri®ed TS primer (5'-AATCCGTCGAGCAGAGTT-3'; NipponGene Co. Ltd.) at 208C for 30 min and then heated to 908C for 3 min to terminate the telomerase reaction. During this step, 0.1 mg (2 ml) extra puri®ed CXII primer (5'-CCCTTACCCT-TACCCTTACCCT-3'; NipponGene Co. Ltd.) was added, and the reaction mixture was subjected to 31 PCR cycles at 948C for 45 s, 508C for 45 s and 728C for 90 s (2 min for ®nal step). Ten ml of PCR product was separated by electrophoresis on a 12% non-denaturating polyacrylamide gel and the 6-base pair ladder and ITAS signal were visualized by autoradiography. In all the series of the TRAP assay, we used an extract of L1210 cells as a positive control and lysis buer as a negative control. The intensity of telomerase ladder and ITAS band were analysed by phosphoimage analyser.
For the semi-quantitative assessment of telomerase activity, the intensity of the telomerase signal (TRAP ladder) was normalized by ITAS signal (ITAS-TRAP assay) (Wright et al., 1995) , as well as by hybridization protection assay (HPA-TRAP assay) measuring telomerase productspeci®c HPA probe (Hirose et al., 1997) . Results from ITAS-TRAP and HPA-TRAP were parallel. In HPA-TRAP assay, uorescent intensity versus amount of cell extract showed linearity by semi-log plot from one cell through 1000 cell equivalent extracts of immortal tumor cell line. Telomerase activity in serially diluted extract from 1000 lymphoblastoid cells were compared with that in serially diluted extracts from a tumor cell line, L1210, as a reference standard of the activity. The determined telomerase activities from HPA-TRAP were classi®ed into four grades by approximately 10-fold dierence of intensity; S, as strong as L1210; M, moderate between L1210 and 1/10 of it; W, weak between 1/ 10 and 1/100 of L1210; N, below than 1/100 of L1210 or negative. Examples of corresponding results from ITAS-TRAP were shown in Figure 2 .
Determination of the lengths of the terminal restriction fragments (TRF)
Genomic DNA was puri®ed by DNA extraction kits (Stratagene, La Jolla, CA). Five mg of genomic DNA was digested with restriction endonuclease HinfI (50 U) overnight at 378C. The HinfI digested genomic DNA was precipitated with ethanol containing 1/10 volume of 3 M sodium acetate. The DNA was dissolved in 10 ml of Tris HCl-EDTA buer and 2 ml of 66gel-loading buer (0.25% bromophenol blue, 0.25% xylene cyanol, 30% glycerol) was added, followed by electrophoresis in 16Tris-borate-EDTA buer on 0.7% agarose gels. After electrophoresis, DNA in the gel was denatured by soaking in 0.5 M sodiumhydroxide-1.5 M NaCl for 30 min, neutralized by soaking in 0.5 M Tris HCl (pH 7.5)-1.5 M NaCl for 30 min, transferred to a nylon membrane Hybond N (Amersham Corp, UK), and baked at 808C for 2 h. Digestion and transfer of DNA were con®rmed by staining gel with ethidium bromide. The membrane was hybridized with 5' 32 -P-labeled (TTAGGG) 4 telomeric oligonucleotide probe in 56SSC with 1% SDS for 12 ± 18 h. After hybridization, the ®lter was washed twice with a mixture of 26SSC and 1% SDS for 5 min at 378C, twice with a mixture of 0.26SSC and 1% SDS for 5 min at 378C, and exposed to Fuji XR ®lm with an intensifying screen. The intensity of TRF signal was analysed on a Macintosh computer using the public domain NIH Image program (written by Wayne Rasband at the US National Institutes of Health and available from the Internet by anonymous ftp from zippy.nimh.nih.gov or on¯oppy disk from NTIS, 5285 Port Royal Rd., Spring®eld, VA22161, part number PB93-504868).
Cycling oligonucleotide-primed in situ synthesis (cycling-PRINS)
Metaphase chromosomes were prepared as described in the Cytogenetic and immunological analyses section. To study the localization of telomere sequences, cycling-PRINS was performed by the method of Gosden and Lawson (Gosden and Lawson, 1994) with some modi®cation, as we now brie¯y described. The oligonucleotide of 5'-(TTAGGG) 4 -3' (Sawady, Tokyo) was used as a primer. The reaction mixture was as follows: 1 ml of each of 10 mM dATP, 10 mM dGTP 1mM dTTP and 1 mM biotin-16-dUTP (Boehringer Mannheim, Mannheim); 5 ml of 106Taq buer 2 ml of 20 mM primer, 4 ml of 25 mM MgCl 2 , 0.5 ml of 20 mg/ml BSA, 5 ml of DMSO and 28.5 ml of distilled water. Then 5 units of Taq polymerase (Promega) was added, and the reaction was carried out with a Perkin Elmer Gene Amp In Situ PCR system 1000. First, the slides were heated at 948C for 1 min followed by 25 cycles at 948C for 1 min, at 608C for 1 min, at 758C for 5 min and ®nally at 758C for 10 min. The reaction was stopped with a solution containing 50 mM EDTA and 500 mM NaCl, and the slides were washed. Biotin-16-dUTP was detected with a biotin-detection system (ONCOR, Gaithersburg, MD) consisting of avidin-FITC and an anti-avidin antibody. All the slides were observed under a Nikon OPTIPHOTO-2¯uorescent microscopy and the images were stored by Mac Probe Version 3.2.1. (Perceptive Scienti®c Instruments, Inc., League City, Texas).
